MECHANISM OF ACTION
It relaxes the smooth muscle of the bronchial airways and pulmonary blood vessels and reduces airway responsiveness to histamine, methacholine, adenosine, and allergen. It competitively inhibits type III and type IV phosphodiesterase (PDE), the enzyme responsible for breaking down cyclic AMP in smooth muscle cells, possibly resulting in bronchodilation. Also binds to adenosine A2B receptor and blocks adenosine medialed bronchoconstriction.
DRUG-DRUG INTERACTION
1) ABIRATERONE: the serum concentration of etophylline can be increased when it is combined with abiraterone.
2) ACEBUTOLO: The risk or severity of adverse effect can be increase when acebutolo is combined with etophylline
3) ACETAMINOPHEN: the serum concentration of drug can be increased when it is combined with etophylline
THERAPEUTIC USES
• Treat lung disease: asthma and COPD
No comments:
Post a Comment